SHPH.US Shuttle Pharmaceuticals Inc

Healthcare Biotechnology USA Stocks
3.93 USD
Close of Nov 17, 2026
2.58 27.30
Market cap
USD 18.7M
P/E
-
P/B
1.13x
ROE
-55.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is SHPH.US undervalued?

Graham number

The Graham number of Shuttle Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shuttle Pharmaceuticals Inc fundamental analysis

No fundamental analysis for Shuttle Pharmaceuticals Inc yet.

Shuttle Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shuttle Pharmaceuticals Inc

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Full company profile